Analyses / SBUX
Recovery narrative intact; execution risk remains. P/E 80x signals elevated entry; watch margin trajectory.
A free account reveals SBUX's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
SBUX trades near 52-week highs (108.88) on strong brand resilience and pricing power. 4-quarter dividend yield (2.38%) + 5-yr revenue CAGR 9.6% underpin recovery thesis. Insider buying (20 buys vs 25 sells) shows conviction. Forward P/E 64x cheaper than trailing 80x signals earnings normalization ahead. Comps stabilization + international expansion potential.
▼ Bear Case
Trailing P/E 79.9x is extreme; even forward 64x embeds high growth expectations. EPS down 16.85% YoY — earnings quality deteriorating. Net margin 4.99%, operating margin 7.9% constrain upside. Current ratio 0.723, quick ratio 0.465 flag liquidity pressure; payout ratio 149% unsustainable. Re-rating risk if consumer demand softens or labor costs accelerate.
Valuation
overvalued — score 35/100
Trailing P/E 80x is extreme; forward 64x still elevated vs S&P 500 avg ~20x. P/B 64x inflated by low book value (equity degraded by buybacks, leverage). EV/EBITDA 28.8x and price-to-FCF 48.9x confirm premium. Justified ONLY if EPS growth accelerates materially (not evident: -16.85% YoY). Risk/reward skewed to downside at current levels.
Technical Levels
Support · $101.50 (Entry zone floor; recent consolidation base) · $98.50 (Hard stop; 50-day MA approx.) · $95.00 (2-month moving average)
Resistance · $108.88 (52-week high; psychological cap) · $110.00 (Round number; prior swing high) · $115.00 (Target; breakout zone)
Financial Health
Score 54/100. Liquidity under pressure; quick ratio 0.465 signals tight working capital. Payout ratio 149% is red flag — unsustainable without earnings recovery or dividend cut. Margins thin but stable. Debt structure not disclosed; assume moderate leverage typical of QSR (quick-service restaurant).
Catalysts
| Q1 2024 earnings (Feb); watch comp sales, margin guidance | Next 2–4 weeks | high |
| US same-store sales stabilization or inflection (monthly/quarterly data) | Ongoing | high |
| International expansion updates (China recovery, Europe) | Next 2–3 months | medium |
| Dividend announcement or cut (if payout unsustainable) | Next quarter | high |
| Labor cost inflation, wage negotiation outcomes | Q1–Q2 2024 | high |
Risk Flags
See SBUX's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock SBUX free →You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full SBUX analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
SBUX FAQ
Is SBUX a buy right now?
Starbucks Corp's current read is a Recovery / Momentum setup with 62 confidence over a 3-6 months horizon. Valuation: overvalued. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is SBUX overvalued?
overvalued (valuation score 35/100). Trailing P/E 80x is extreme; forward 64x still elevated vs S&P 500 avg ~20x. P/B 64x inflated by low book value (equity degraded by buybacks, leverage). EV/EBITDA 28.8x and price-to-FCF 48.9x confirm premium. Justified ONLY if EPS growth accelerates materially (not evident: -16.85% YoY). Risk/reward skewed to downside at current levels.
What are the risks of buying SBUX?
Trailing P/E 79.9x is extreme; even forward 64x embeds high growth expectations. EPS down 16.85% YoY — earnings quality deteriorating. Net margin 4.99%, operating margin 7.9% constrain upside. Current ratio 0.723, quick ratio 0.465 flag liquidity pressure; payout ratio 149% unsustainable. Re-rating risk if consumer demand softens or labor costs accelerate.